Cell therapy trial offers new hope to liver disease patients
Posted: November 25, 2014 at 2:43 pm
PUBLIC RELEASE DATE:
24-Nov-2014
Contact: Jen Middleton jen.middleton@ed.ac.uk 44-131-650-6514 University of Edinburgh @uniofedinburgh
Liver disease patients could be helped by a new cell therapy to treat the condition.
Researchers from the University of Edinburgh have received funding to start testing the therapy in patients within the next year.
It will be the world's first clinical trial of a new type of cell therapy to treat liver cirrhosis, a common disease where scar tissue forms in the organ as a result of long-term damage.
The Edinburgh team has received funding from the Medical Research Council and Innovate UK to investigate the disease, which claims 4000 lives in the UK each year.
The only successful treatment for end-stage liver cirrhosis at present is an organ transplant. The new therapy is based on a type of white blood cell called a macrophage, which is key to normal repair processes in the liver.
Macrophages reduce scar tissue and stimulate the liver's own stem cells to expand and form into healthy new liver cells.
Scientists will take cells from the blood of patients with liver cirrhosis and turn them into macrophages in the lab using chemical signals.
Continue reading here:
Cell therapy trial offers new hope to liver disease patients